PHX — Pharmx Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- AU$45.49m
- AU$41.19m
- AU$6.78m
- 89
- 48
- 95
- 89
Annual cashflow statement for Pharmx Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.12 | 2.08 | 1.97 | 10.1 | 2.01 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.369 | 3.16 | 3.28 | 10.9 | 3.21 |
| Capital Expenditures | -3.28 | -4.09 | -3.98 | -3.36 | -1.58 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.052 | -2.1 | 0.336 | -0.213 | 3.33 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.34 | -6.19 | -3.64 | -3.57 | 1.75 |
| Financing Cash Flow Items | -0.352 | -0.427 | -0.043 | -0.012 | -0.016 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.96 | 7.18 | -0.361 | -0.325 | -4.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.01 | 4.16 | -0.719 | 7.05 | 0.33 |